Patient characteristics associated with the need for high doses of tenapanor hydrochloride in dialysis patients with hyperphosphatemia: A pooled analysis of three clinical trials. [PDF]
PLoS OneNagano N +4 more
europepmc +1 more source
Emerging treatments and current strategies for mineral, vascular, and bone disorders in chronic kidney disease. [PDF]
World J NephrolIlkun O, Jazayeri F, Kazory A.
europepmc +1 more source
Evanescent extraosseous calcifications in low turnover bone: management and outcomes: a case report. [PDF]
Front NephrolHernandez-Pérez M, Enos D.
europepmc +1 more source
The role of nutritional vitamin D on microinflammation and nutritional status in maintenance hemodialysis patients: a meta-analysis of randomized controlled trials. [PDF]
Front NutrLi C, Xu S, Wang Y, Wu M.
europepmc +1 more source
Internal Inconsistencies Between Reported Profiles, Predictors, and Conclusions. [PDF]
Ther Apher DialCankaya E.
europepmc +1 more source
Sevelamer inhibits the formation of cholesterol gallstones by modulating bile acid metabolism. [PDF]
Front PharmacolShen S +8 more
europepmc +1 more source
Association between Phosphate Binders and Constipation in Patients Undergoing Chronic Hemodialysis: A Cross-sectional Study. [PDF]
Intern MedHori M +5 more
europepmc +1 more source
[Normophosphatemic familial tumoral calcinosis: description of a case with phosphate lowering therapy]. [PDF]
Probl Endokrinol (Mosk)Vitebskaya AV +2 more
europepmc +1 more source
Marked regression of calcinosis with canakinumab in hyperphosphatemic familial tumoral calcinosis. [PDF]
JBMR PlusDauchez A +7 more
europepmc +1 more source
Sevelamer-Associated Colitis as a Colon Cancer Mimicker. [PDF]
Gastro Hep AdvDoll B +4 more
europepmc +1 more source